Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor Conferences
November 12 2020 - 10:00AM
Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative products
that enhance clinical outcomes, today announced that it will be
participating in the upcoming Craig-Hallum and Canaccord Genuity
investor conferences in November. Misonix Chief Executive Officer,
Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial
Officer, will be available to host one-on-one meetings with
investors who are registered to attend the conferences.
-
Craig-Hallum
11thAnnual Alpha Select
ConferenceDate: Tuesday, November 17th
- Canaccord Genuity Virtual
MedTech & Diagnostics ForumDate: Thursday, November
19th
For more information about the conferences or to
schedule a virtual one-on-one meeting with management, please
contact your conference representative. Alternatively, please
contact Misonix’s investor relations firm, JCIR,
at mson@jcir.com.
About Misonix, Inc. Misonix,
Inc. (Nasdaq: MSON) is a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative tissue
products. Its surgical team markets and sells BoneScalpel and
SonaStar, which facilitate precise bone sculpting and removal of
soft and hard tumors and tissue, primarily in the areas of
neurosurgery, orthopedic, plastic and maxillo-facial surgery. The
Company's wound team markets and sells TheraSkin, Therion,
TheraGenesis and SonicOne to debride, treat and heal chronic and
traumatic wounds in inpatient, outpatient and physician office
sites of service. At Misonix, Better Matters! That is why
throughout the Company’s history, Misonix has maintained
its commitment to medical technology innovation and the development
of products that radically improve outcomes for patients.
Additional information is available on the Company's web site at
www.misonix.com.
|
|
Contact: |
|
Joe Dwyer |
Norberto Aja, Jennifer Neuman |
Chief Financial Officer |
JCIR |
Misonix, Inc. |
212-835-8500 or mson@jcir.com |
631-927-9113 |
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2024 to May 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From May 2023 to May 2024